|
    AMGN U.S.: Nasdaq

    Amgen Inc.

    Watchlist
    AMGNUS
    Premarket
    Last Updated: Jul 31, 2023 6:48 a.m. EDT Delayed quote

    $ 237.01

    0.64 0.27%
    Before Hours Volume: 58
    Close Chg Chg %
    $236.37 0.32 0.14%
    Advanced Charting
    Volume: 1.89M 65 Day Avg: 2.55M
    74% vs Avg
    235.09 Day Range 238.18
    211.71 52 Week Range 296.67

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Create Account … or Log In
    Symbol
    Company
    Price
    Chg/Chg %
    (Go to Your Watchlist)
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Add Tickers
    No Saved Watchlists

    Create a list of the investments you want to track.

    Create Watchlist …or learn more
    Uh oh

    Something went wrong while loading Watchlist.

    Go to Watchlist

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    Overview

  • Overview
  • Profile
  • Charts
  • Financials
  • Historical Quotes
  • Analyst Estimates
  • Options
  • Premium Tools

    • AMGN Overview

    Key Data

    • Open $236.82
    • Day Range 235.09 - 238.18
    • 52 Week Range 211.71 - 296.67
    • Market Cap $126.3B
    • Shares Outstanding 534.33M
    • Public Float 533.12M
    • Beta 0.65
    • Rev. per Employee $1.029M
    • P/E Ratio 16.06
    • EPS $14.71
    • Yield 3.60%
    • Dividend $2.13
    • Ex-Dividend Date May 17, 2023
    • Short Interest 7.18M 07/14/23
    • % of Float Shorted 1.35%
    • Average Volume 2.55M

    Performance

    5 Day
    • 0.40%
    1 Month
    • 5.05%
    3 Month
    • -1.06%
    YTD
    • -10.00%
    1 Year
    • -3.77%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 26 Full Ratings

    Recent News

    Read full story

    Financials With Hurricane Season Looming, Florida Faces an Insurance Meltdown

    Jul. 28, 2023 at 8:02 p.m. ET by Barron's
    Read full story

    Amgen Inc. stock rises Friday, still underperforms market

    Jul. 28, 2023 at 4:40 p.m. ET by MarketWatch Automation
    Read full story

    Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains

    Jul. 27, 2023 at 4:40 p.m. ET by MarketWatch Automation
    Read full story

    Amgen Inc. stock underperforms Wednesday when compared to competitors

    Jul. 26, 2023 at 4:40 p.m. ET by MarketWatch Automation
    Read full story

    Amgen Inc. stock falls Tuesday, underperforms market

    Jul. 25, 2023 at 4:40 p.m. ET by MarketWatch Automation
    Read full story

    Amgen Inc. stock rises Monday, still underperforms market

    Jul. 24, 2023 at 4:40 p.m. ET by MarketWatch Automation
    Read full story

    Drug manufacturers’ deal making will plow ahead despite antitrust scrutiny, according to analysts

    Jul. 12, 2023 at 3:59 p.m. ET by Eleanor Laise
    Read full story

    These companies have beaten the Rule of 40 year after year

    Jul. 11, 2023 at 4:59 a.m. ET by Steve Goldstein
    Read full story

    Biotech and Pharma 4 Big Pharma Stocks On Sale Right Now

    Jul. 6, 2023 at 10:53 a.m. ET by Barron's

    Amgen Gets FDA Approval for Blincyto Supplemental Biologics License Application

    Jun. 21, 2023 at 9:31 a.m. ET
    Read full story

    Regulation Washington Is Coming Down Hard on Deal Making. What It Means for Stocks.

    May. 19, 2023 at 1:56 p.m. ET by Barron's

    Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen

    May. 18, 2023 at 12:39 p.m. ET
    Read full story

    Healthcare Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider

    May. 17, 2023 at 12:38 p.m. ET by Barron's
    Read full story

    FTC sues to block Amgen’s acquisition of Horizon Therapeutics

    May. 17, 2023 at 8:29 a.m. ET by Eleanor Laise
    Read full story

    Biotech and Pharma FTC Sues to Block Amgen’s $27.8 Billion Acquisition of Horizon Therapeutics

    May. 16, 2023 at 12:41 p.m. ET by Barron's
    Read full story

    Horizon shares sink on report that FTC will sue to block takeover by Amgen

    May. 16, 2023 at 7:52 a.m. ET by Mike Murphy
    Read full story

    Home Depot slips and Capital One gains

    May. 16, 2023 at 7:09 a.m. ET by Jamie Chisholm

    Home Depot’s stock selloff would cut nearly 80 points off the Dow’s price

    May. 16, 2023 at 7:07 a.m. ET by Tomi Kilgore

    Horizon Shares Slide Premarket on Report That FTC to Fight Amgen Deal

    May. 16, 2023 at 5:59 a.m. ET

    TScan Therapeutics Shares Take Flight on Amgen Pact >TCRX

    May. 9, 2023 at 9:38 a.m. ET

    The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets

    Jul. 28, 2023 at 4:06 p.m. ET

    Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated

    Jul. 28, 2023 at 11:56 a.m. ET

    3 Things About Johnson & Johnson Every Smart Investor Knows

    Jul. 28, 2023 at 8:37 a.m. ET

    Check Out What Whales Are Doing With AMGN

    Jul. 27, 2023 at 3:31 p.m. ET

    AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View

    Jul. 27, 2023 at 1:05 p.m. ET

    AbbVie's Skyrizi Achieves Superiority Versus Amgen's Drug In Head-to-Head Study In Moderate Plaque Psoriasis

    Jul. 26, 2023 at 12:25 p.m. ET

    Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries

    Jul. 26, 2023 at 9:06 a.m. ET

    Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Biogen (BIIB)

    Jul. 26, 2023 at 12:20 a.m. ET

    2 Cheap High-Yield Dividend Stocks to Buy Now

    Jul. 25, 2023 at 11:15 a.m. ET

    Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?

    Jul. 25, 2023 at 6:20 a.m. ET

    Amgen (AMGN) Gains But Lags Market: What You Should Know

    Jul. 24, 2023 at 5:50 p.m. ET

    Mirati (MRTX) Down 7% on CHMP's Opinion on Krazati Filing

    Jul. 24, 2023 at 11:23 a.m. ET

    Horizon's (HZNP) Daxdilimab Fails to Meet Goal in Lupus Study

    Jul. 24, 2023 at 11:12 a.m. ET

    Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

    Jul. 24, 2023 at 9:00 a.m. ET

    Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

    Jul. 24, 2023 at 6:20 a.m. ET

    The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

    Jul. 21, 2023 at 3:31 p.m. ET

    Should You Invest in the iShares Biotechnology ETF (IBB)?

    Jul. 19, 2023 at 6:20 a.m. ET

    Softbank, Amgen-Backed Neumora Therapeutics Unveils Plans For Three Phase 3 Studies For Major Depressive Disorder

    Jul. 18, 2023 at 2:23 p.m. ET

    3 Biotech Stocks for Getting Rich in 2023

    Jul. 18, 2023 at 6:22 a.m. ET

    Amgen (AMGN) Gains But Lags Market: What You Should Know

    Jul. 17, 2023 at 5:50 p.m. ET

    Amgen Inc.

    Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 0.45% $453.43B
    Pfizer Inc. -0.36% $203.63B
    Novo Nordisk A/S Series B 2.46% kr.2.35T
    AbbVie Inc. 1.34% $266.14B
    AstraZeneca PLC ADR 3.47% $220.47B
    AstraZeneca PLC 0.54% £171.39B
    Moderna Inc. 0.13% $45.23B
    Gilead Sciences Inc. 0.46% $95.87B
    Regeneron Pharmaceuticals Inc. 0.19% $81.84B
    Lonza Group AG 0.16% CHF37.48B